Organ on Chip: Explore References from Our Customers and Scientists
Stay up-to-date with the latest organ on chip research and advancements by accessing publications from our worthy customers and dedicated scientists.
Gain valuable insights, discover novel findings, and learn about the impact of our technologies in various research areas.
2022 - Front Oncol - Decellularization of xenografted tumors provides cell-specific in vitro 3D environment. - Iazzolino G et al.- Read more…
2022 - Front Cell Dev Biol - A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors. - Golinelli G et al.- Read more…
2022 - Cells - Scalable Production of Size-Controlled Cholangiocyte and Cholangiocarcinoma Organoids within Liver Extracellular Matrix-Containing Microcapsules. - van Tienderen GS et al.- Read more…
2022 - Cells - In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment. - Krysko DV et al.- Read more…
2022 - Cancers (Basel) - Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants. - Bottino C et al.- Read more…
2022 - Cancers (Basel) - In Vitro Setup for Determination of Nanoparticle-Mediated Magnetic Cell and Drug Accumulation in Tumor Spheroids under Flow Conditions. - Behr J et al.- Read more…
2022 - Metabolites - Availability and Metabolic Fate of Olive Phenolic Alcohols Hydroxytyrosol and Tyrosol in the Human GI Tract Simulated by the In Vitro GIDM-Colon Model. - Sakavitsi ME et al.- Read more…
2022 - Cancers (Basel) - 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs. - Barbosa MAG et al.- Read more…
2022 - J Exp Clin Cancer Res - Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. - Pescatori S et al.- Read more…
2022 - Cancers (Basel) - The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery. - Bae J et al.- Read more…

